BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15992737)

  • 1. Detection of drug-induced proarrhythmia: balancing preclinical and clinical studies.
    Malik M
    Heart Rhythm; 2005 Jul; 2(7):773-6. PubMed ID: 15992737
    [No Abstract]   [Full Text] [Related]  

  • 2. Refining detection of drug-induced proarrhythmia: QT interval and TRIaD.
    Shah RR; Hondeghem LM
    Heart Rhythm; 2005 Jul; 2(7):758-72. PubMed ID: 15992736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A heartless brain.
    Chauveau S; Derex L; Chevalier P
    Europace; 2013 Jun; 15(6):848. PubMed ID: 23349457
    [No Abstract]   [Full Text] [Related]  

  • 4. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
    Jacobson I; Carlsson L; Duker G
    J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torsade de pointes and prolonged QT interval from surreptitious use of sotalol: use of drug levels in diagnosis.
    Link MS; Foote CB; Sloan SB; Homoud MK; Wang PJ; Estes NA
    Chest; 1997 Aug; 112(2):556-7. PubMed ID: 9266902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E; Watson T; Lip GY
    Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Preclinical evaluation of drug induced QT prolongation].
    Hashimoto K
    Nihon Yakurigaku Zasshi; 2003 Jun; 121(6):408-10. PubMed ID: 12899128
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiologist's point of view: Novel ECG biomarkers and in silico models for proarrhythmic risk prediction: Are we ready?
    Mason JW
    J Electrocardiol; 2017; 50(6):825-827. PubMed ID: 28919218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long QT syndrome caused by noncardiac drugs.
    Viskin S; Justo D; Halkin A; Zeltser D
    Prog Cardiovasc Dis; 2003; 45(5):415-27. PubMed ID: 12704598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Torsade de Pointes during mild hypothermia therapy for a survivor of sudden cardiac arrest due to drug-induced long-QT syndrome.
    Matsuhashi T; Sato T; Aizawa Y; Takatsuki S
    J Cardiovasc Electrophysiol; 2010 Apr; 21(4):462-3. PubMed ID: 19845813
    [No Abstract]   [Full Text] [Related]  

  • 11. QT interval prolongation and torsade de pointes associated with indapamide. Comments to Letsas et al.
    Perciaccante A; Fiorentini A
    Int J Cardiol; 2007 Nov; 122(3):255; author reply 256-7. PubMed ID: 17368589
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K; Dorian P
    Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline.
    Dorsey ST; Biblo LA
    Am J Emerg Med; 2000 Mar; 18(2):227-9. PubMed ID: 10750939
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long QT syndrome due to olanzapine administration].
    Janion M; Dudek A; Sielski J; Janion-Sadowska A
    Kardiol Pol; 2006 Sep; 64(9):986-8. PubMed ID: 17054030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic agents associated with QT interval prolongation.
    Olsen KM
    J Fam Pract; 2005 Jun; Suppl():S8-S14. PubMed ID: 15938993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced prolongation of the QT interval.
    Curigliano G; Cipolla C; de Braud F
    N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208787
    [No Abstract]   [Full Text] [Related]  

  • 17. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram-induced long QT syndrome and torsade de pointes: role for concomitant therapy and disease.
    de Gregorio C; Morabito G; Cerrito M; Dattilo G; Oreto G
    Int J Cardiol; 2011 Apr; 148(2):226-8. PubMed ID: 19540606
    [No Abstract]   [Full Text] [Related]  

  • 19. Voriconazole-induced QT interval prolongation and torsades de pointes.
    Aypar E; Kendirli T; Tutar E; Çiftçi E; Ince E; Ileri T; Atalay S
    Pediatr Int; 2011 Oct; 53(5):761-763. PubMed ID: 21955009
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug-induced QT prolongation.
    Tzivoni D
    Isr Med Assoc J; 2001 Jun; 3(6):472. PubMed ID: 11433657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.